Patent · US Active

Hybrid bioelectrical interface device

US9044347B2 · kind B2 · utility

5Cited by
33References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2012
Grant dateJun 2, 2015
Priority date
Expiry dateAug 15, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0001
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A hybrid bioelectrical interface (HBI) device can be an implantable device comprising an abiotic component operable to transmit charge via electrons or ions; a biological component interfacing with the neural tissue, the biological component being sourced from biologic, biologically-derived, or bio-functionalized material; and a conjugated polymer component that together provide a way to chronically interface living neural tissue with electronic devices for extended durations (e.g. greater than 10 years). In some embodiments, conjugated polymers provide a functional electrical interface for charge transfer and signal transduction between the nervous system and an electronic device (e.g. robotic prosthetic limb, retinal implant, microchip).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.